Table 4

Outcomes according to guideline

Guideline Applicable to DXATreatment recommendedHigh risk not recommended treatmentLow risk unnecessarily treated
BSG100% (132)88% (116)30% (39)8% (7/93)62% (24/39)
NICE30% (40)17% (7)12% (5)3% (1/35)60% (3/5)
FRAX/NOGG78% (103)27% (28)15% (15)13% (11/88)40% (6/15)
  • BSG, British Society of Gastroenterology; DXA, dual-emission x-ray absorptiometry; FRAX, fracture risk assessment tool; NICE, National Institute for Health and Clinical Excellence; NOGG, National Osteoporosis Guidelines Group.